ERIN BRAZZALE: Open Payments
NPI 1104566090 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,929 in 95 payments from 14 companies in 2025. Trend: 2023 $573 · 2024 $1,981 · 2025 $1,929
Food & beverage: $1,874Education: $55
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $316 |
| GENZYME CORPORATION | 11 | $313 |
| Janssen Biotech, Inc. | 11 | $275 |
| UCB, Inc. | 12 | $233 |
| ABBVIE INC. | 12 | $211 |
| Regeneron Healthcare Solutions, Inc. | 7 | $142 |
| Organon LLC | 10 | $136 |
| Galderma Laboratories, L.P. | 5 | $85 |
| PFIZER INC. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: DUPIXENT, TREMFYA, COSENTYX, Bimzelx, SKYRIZI, NEMLUVIO, Rhapsido, VTAMA.
Industry payments across CO — which companies pay providers there.
